HEMANEXT SUBMITS HEMANEXT ONE® SYSTEM TO FDA FOR U.S. MARKETING AUTHORIZATION

LEXINGTON, Mass.: LEXINGTON, Mass., Jan. 5, 2022 /PRNewswire/ -- Hemanext Inc., a leading innovator in blood processing and storage technology, announced that it submitted the Hemanext ONE® system for marketing authorization review by the U.S. Food and Drug Administration (FDA) on December 30, 2021. The innovative Hemanext ONE® RBC Processing...

Click to view original post